Andrew J. Einhorn - May 18, 2021 Form 4 Insider Report for Osmotica Pharmaceuticals plc (RVLP)

Role
Chief Financial Officer
Signature
By: /s/ Christopher Klein, as attorney-in-fact
Stock symbol
RVLP
Transactions as of
May 18, 2021
Transactions value $
-$20,177
Form type
4
Date filed
5/20/2021, 04:06 PM
Next filing
Nov 8, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RVLP Ordinary Shares Tax liability -$20.2K -6.47K -4.1% $3.12* 151K May 18, 2021 Direct
holding RVLP Ordinary Shares 22.9K May 18, 2021 By family limited liability company F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Reporting Person is the sole managing member of the limited liability company and, as a result, may be deemed to beneficially own the ordinary shares held by the limited liability company. The Reporting Person disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein.